Asymmetrical dimethylarginine as a mediator of endothelial dysfunction in acute inflammation at different disease stages
Príomhchruthaitheoirí: | Demosthenous, M, Antoniades, C, Antonopoulos, S, Tousoulis, D, Bakogiannis, C, Vlachopoulos, C, Petrochilou, K, Toutouza, M, Channon, K, Stefanadis, C |
---|---|
Formáid: | Conference item |
Foilsithe / Cruthaithe: |
2010
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011) -
Haplotype on GTP-Cyclohydrolase I Gene, Reveals a Novel Role of Tetrahydrobiopterin as a Defense Mechanism Against Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011) -
Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011) -
NADPH-oxidase activity in peripheral blood mononuclear cells as a novel inflammatory marker in atherosclerosis
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2010) -
Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis.
de réir: Antoniades, C, et al.
Foilsithe / Cruthaithe: (2011)